- Clinical trials test new drugs in many places.
- Few trials reflect people in the United States.
- Black people are often underrepresented in trials.
- Hispanic people are often underrepresented too.
- Asian representation has increased over time.
- White participation has stayed mostly stable.
- Many trials run only in a few regions.
- Parts of Africa and Latin America are left out.
- Researchers say we need more diversity early.
- This change can affect how drugs work.
Difficult words
- clinical trial — A study to test a new medicine.Clinical trials
- underrepresented — Not having enough people from a group.
- representation — The presence or number of a group.
- diversity — Many different kinds of people in a group.
- region — A large area or part of a country.regions
- researcher — A person who studies and tests things.Researchers
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you join a clinical trial?
- Should trials include people from different regions?
Related articles
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.
Psychedelics change blood-flow signals in brain imaging
Researchers at Washington University found that psychedelics acting on serotonin can disrupt the normal link between neuronal activity and blood flow in mice. Similar effects appeared with psilocybin and in reanalyzed human fMRI data.
Algae-based synthetic gel supports mammary tissue growth
In 2020 a PhD student and her adviser at UC Santa Barbara developed an algae-based synthetic membrane to support mammary epithelial cells. Their tunable gel, reported in Science Advances, can direct cell growth by changing mechanical and biochemical cues.